Table 1.
Clinical data from all patients with LNB and HIV reported in literature.
| Case no.* | Anti-retroviral | Antibiotic prophylaxis | Skin manifestations | Presentation | Treatment | Clinical recovery |
|---|---|---|---|---|---|---|
| 1 | none | none | Annular erythematous lesion | Several weeks later: fever, bilateral facial palsy | IV ceftriaxone 2 g/day 14 days | After treatment vast improvement 2 months, complete recovery |
| 2 | Zidovudine | none reported | Erythema | Headache, painful limbs, weight loss, pneumonia | Primairily: PO Azithromycin | Progression to neuroborreliosis |
| Saquinavir | 1 day 500 mg, 4 days 250 mg | |||||
| Zalcitabine | 2 weeks later: fever, diplopia | IV ceftriaxone 2 g/day 14 days | Improved rapidly | |||
| 3 | Zidovudine | none reported | Erythematous lesion | 4 weeks later:: radiculitis | IV ceftriaxone 2 g/day 15 days | Complete recovery |
| Didanosine | 18 months, no relapse | |||||
| 4 | none | none reported | Multiple | Fever, chills, arthralgias | IV ceftotaxime 2 g TID 21 days | After treatment mild facial palsy |
| Maculous erythemas | 2 weeks later left facial palsy | 6 months, slight hypokinesia face | ||||
| 5 | Zidovudine | none | None | Altered gait for months | IV ceftriaxone 2 g/day 1 month | After treatment severe sequelae |
| Lamivudine | 3 years, no relapse | |||||
| Nevirapine |